170 related articles for article (PubMed ID: 18253741)
41. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
Li S; Zhan H; Peng S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
43. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.
Ergün S; Zheng X; Carlsöö B
Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107
[TBL] [Abstract][Full Text] [Related]
44. Indocyanine green-augmented diode laser therapy of telangiectatic leg veins: a randomized controlled proof-of-concept trial.
Klein A; Bäumler W; Koller M; Shafirstein G; Kohl EA; Landthaler M; Babilas P
Lasers Surg Med; 2012 Jul; 44(5):369-76. PubMed ID: 22488578
[TBL] [Abstract][Full Text] [Related]
45. Expression of human intercellular adhesion molecules in middle ear cholesteatoma.
Bujía J; Holly A; Kim C; Scanady N; Kastenbauer E
Am J Otolaryngol; 1994; 15(4):271-5. PubMed ID: 7526720
[TBL] [Abstract][Full Text] [Related]
46. [Proliferation behavior of cholesteatoma].
Hoppe F
HNO; 1995 Dec; 43(12):710-5. PubMed ID: 8582830
[TBL] [Abstract][Full Text] [Related]
47. Reversibility of experimental cholesteatoma epithelium using Mongolian gerbils.
Park K; Choung YH; Chun YM; Lee JS; Hong SP
Acta Otolaryngol; 2005 May; 125(5):540-6. PubMed ID: 16092548
[TBL] [Abstract][Full Text] [Related]
48. Lasers in Cholesteatoma Surgery: A Systematic Review.
Lau K; Stavrakas M; Yardley M; Ray J
Ear Nose Throat J; 2021 Feb; 100(1_suppl):94S-99S. PubMed ID: 32809846
[TBL] [Abstract][Full Text] [Related]
49. [Expression of calgranulin A and B in middle ear cholesteatoma].
Holly A; Bujía J; Lempart K; Serge M
Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019
[TBL] [Abstract][Full Text] [Related]
50. A study on epidermal proliferation ability in cholesteatoma.
Tanaka Y; Shiwa M; Kojima H; Miyazaki H; Kamide Y; Moriyama H
Laryngoscope; 1998 Apr; 108(4 Pt 1):537-42. PubMed ID: 9546266
[TBL] [Abstract][Full Text] [Related]
51. Expression of annexin II in human middle ear cholesteatoma.
Kim TT; Chen CT; Huang CC
Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):324-8. PubMed ID: 9527111
[TBL] [Abstract][Full Text] [Related]
52. Indocyanine green-augmented diode laser therapy vs. long-pulsed Nd:YAG (1064 nm) laser treatment of telangiectatic leg veins: a randomized controlled trial.
Klein A; Buschmann M; Babilas P; Landthaler M; Bäumler W
Br J Dermatol; 2013 Aug; 169(2):365-73. PubMed ID: 23646932
[TBL] [Abstract][Full Text] [Related]
53. Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?
Ottaviani F; Neglia CB; Berti E
Acta Otolaryngol; 1999; 119(4):462-7. PubMed ID: 10445062
[TBL] [Abstract][Full Text] [Related]
54. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.
Sastry KV; Sharma SC; Mann SB; Ganguly NK; Panda NK
Am J Otol; 1999 Mar; 20(2):158-61. PubMed ID: 10100515
[TBL] [Abstract][Full Text] [Related]
55. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
Niu F; Wang L; Zhang W; Lyu S; Niu Y
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
[TBL] [Abstract][Full Text] [Related]
56. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.
Kojima H; Shiwa M; Kamide Y; Moriyama H
Acta Otolaryngol; 1994 Jul; 114(4):423-9. PubMed ID: 7976315
[TBL] [Abstract][Full Text] [Related]
57. Colony-stimulating factor in middle ear cholesteatoma.
Huang T; Yan SD; Huang CC
Am J Otolaryngol; 1989; 10(6):393-8. PubMed ID: 2688444
[TBL] [Abstract][Full Text] [Related]
58. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
Kinoshita K
Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
[TBL] [Abstract][Full Text] [Related]
59. [A study on expression of tumor necrosis factor alpha in middle ear cholesteatoma and its effect on bone destruction].
Li Z; Li X; Liu G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):66-7. PubMed ID: 12541866
[TBL] [Abstract][Full Text] [Related]
60. Imaging guidance for cholesteatoma surgery using tissue autofluorescence.
Yang S; Farrell J; Ye S; Ahmad I; Valdez TA
J Biomed Opt; 2023 Jun; 28(6):066003. PubMed ID: 37334207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
